Loading...
•
Sep 30
Option Care Health Q3 2025 Earnings Report
Option Care Health reported its financial results for the third quarter ended September 30, 2025.
Key Takeaways
Option Care Health delivered a strong third quarter with net revenue increasing by 12.2% year-over-year to $1.435 billion. While net income saw a slight decrease of 3.8%, adjusted diluted EPS grew by 9.8% to $0.45, and adjusted EBITDA increased by 3.4% to $119.5 million, demonstrating balanced growth and operational strength.
Net revenue increased by 12.2% year-over-year, reaching $1,435.0 million.
Adjusted diluted earnings per share grew by 9.8% to $0.45.
Adjusted EBITDA increased by 3.4% to $119.5 million.
The company repurchased $62.5 million of stock during the quarter.
Option Care Health
Option Care Health
Forward Guidance
For the full year 2025, Option Care Health updated its financial guidance, expecting net revenue between $5.60 billion and $5.65 billion, adjusted diluted EPS between $1.68 and $1.72, and adjusted EBITDA between $468 million and $473 million. Cash flow from operations is projected to be at least $320 million.
Positive Outlook
- Expected net revenue of $5.60 billion to $5.65 billion for full year 2025.
- Anticipated adjusted diluted EPS of $1.68 to $1.72 for full year 2025.
- Projected adjusted EBITDA of $468 million to $473 million for full year 2025.
- Expected cash flow from operations of at least $320 million for full year 2025.
- Effective tax rate of 25% to 27%.
Challenges Ahead
- Net interest expense of approximately $55 million to $57 million, indicating ongoing debt servicing costs.
- The guidance does not explicitly mention specific growth targets for net income, focusing more on adjusted metrics.
- No specific negative forward-looking statements were provided in the report.
- The report does not detail potential challenges in achieving the guidance.
- No specific negative impacts from the 'dynamic regulatory environment' or 'changing competitive landscapes' were quantified in the guidance.